HCPCS Level II · Procedures and professional services (temporary)
G9962Embolization endpoints are documented separately for each embolized vessel and ovarian artery angiography or embolization performed in the presence of variant uterine artery anatomy
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About G9962
G9962 is an HCPCS Level II code in the G series (procedures and professional services (temporary)), describing embolization endpoints are documented separately for each embolized vessel and ovarian artery angiography or embolization performed in the presence of variant uterine artery anatomy.
It was added to HCPCS effective 01/01/2018.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Embolization doc separatly
- Date added
- 01/01/2018
- Action effective
- 01/01/2018
- BETOS
- Z2
Related G99xx codes
- G9900Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified
- G9901Patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement period
- G9902Patient screened for tobacco use and identified as a tobacco user
- G9903Patient screened for tobacco use and identified as a tobacco non-user
- G9905Patient not screened for tobacco use
- G9906Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)
- G9908Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)
- G9910Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period
- G9911Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer before or after neoadjuvant systemic therapy
- G9912Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy
- G9913Hepatitis b virus (hbv) status not assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy, reason not otherwise specified
- G9914Patient initiated an anti-tnf agent
Common questions about G9962
Is HCPCS G9962 still valid?
- Yes. G9962 is active in the CMS October 2026 HCPCS file.
Does Medicare cover G9962?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.